Patents Assigned to Medisyn Technologies, Inc.
  • Therapeutic compound and treatments
    Patent number: 8088785
    Abstract: Compositions and uses associated with the MT477 family of compounds are disclosed. Particular structural features and properties of the compounds are described in detail. Uses include administering an MT477 family member to a patient for therapeutic purposes. Compositions include chemicals belonging to the MT477 family and pharmaceuticals that contain such chemicals.
    Type: Grant
    Filed: December 10, 2009
    Date of Patent: January 3, 2012
    Assignee: Medisyn Technologies, Inc.
    Inventors: Javier Llompart, Jorge Galvez, Kollol Pal
  • THERAPEUTIC COMPOUND AND TREATMENTS
    Publication number: 20100137253
    Abstract: Compositions and uses associated with the MT477 family of compounds are disclosed. Particular structural features and properties of the compounds are described in detail. Uses include administering an MT477 family member to a patient for therapeutic purposes. Compositions include chemicals belonging to the MT477 family and pharmaceuticals that contain such chemicals.
    Type: Application
    Filed: December 10, 2009
    Publication date: June 3, 2010
    Applicant: Medisyn Technologies, Inc.
    Inventors: Javier Llompart, Jorge Galvez, Kollol Pal
  • Therapeutic compound and treatments
    Patent number: 7652029
    Abstract: Compositions and uses associated with the MT477 family of compounds are disclosed. Particular structural features and properties of the compounds are described in detail. Uses include administering an MT477 family member to a patient for therapeutic purposes. Compositions include chemicals belonging to the MT477 family and pharmaceuticals that contain such chemicals.
    Type: Grant
    Filed: July 11, 2005
    Date of Patent: January 26, 2010
    Assignee: Medisyn Technologies, Inc.
    Inventors: Javier Llompart, Jorge Galvez, Kollol Pal
  • Therapeutic agents and corresponding treatments
    Patent number: 6919376
    Abstract: Compositions and methods of using an MT103 family member, wherein MT103 is the chemical N,N-dicyclohexyl-(1S)-isoborneol-10-sulfonamide. Uses of the compositions include cancer therapy, antibacterials, antifungals, induction of apoptosis, and hormonal antagonists.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: July 19, 2005
    Assignee: Medisyn Technologies, Inc.
    Inventors: Javier Llompart, Jorge Galvez